HLB Co., Ltd. (KOSDAQ:028300)
South Korea
· Delayed Price · Currency is KRW 51,200
+600 (1.19%)
Jul 11, 2025, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 6.64 trillion as of July 11, 2025. Its market cap has decreased by -16.12% in one year.
Market Cap
6.64T
Enterprise Value
6.79T
Revenue
74.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,200.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 6.64T, an increase of 49,213.13%. That is a compound annual growth rate of 45.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 6,637.29B | -30.76% |
| Dec 30, 2024 | 9,585.71B | 46.53% |
| Dec 28, 2023 | 6,541.97B | 98.02% |
| Dec 29, 2022 | 3,303.67B | -10.84% |
| Dec 30, 2021 | 3,705.38B | -24.18% |
| Dec 30, 2020 | 4,887.34B | -0.25% |
| Dec 30, 2019 | Pro | Pro |
| Dec 28, 2018 | Pro | Pro |
| Dec 28, 2017 | Pro | Pro |
| Dec 29, 2016 | Pro | Pro |
| Dec 30, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.10T |
| Celltrion | 38.76T |
| ALTEOGEN | 22.39T |
| Yuhan | 7,960.75B |
| SK Biopharmaceuticals | 7,259.64B |
| PharmaResearch | 6,109.11B |
| Peptron | 4,438.15B |
| LigaChem Biosciences | 4,346.63B |